1. Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group
   Ralf-Dieter Hofheinz et al, 2015, Journal of Clinical Oncology CrossRef
2. A pilot randomized double-blind, placebo-controlled study on the effects of the topical application of pyridoxine on palmar-plantar erythrodysesthesia (PPE) induced by capecitabine or pegylated liposomal doxorubicin (PLD)
   Andreas Charalambous et al, 2021, European Journal of Oncology Nursing CrossRef
3. How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs
   Jiexiu Chen et al, 2021, Journal of Oncology Pharmacy Practice CrossRef
4. Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)
   Yohei Iimura et al, 2022, BMC Gastroenterology CrossRef
5. Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial
   Reo Hamaguchi et al, 2018, BMJ Open CrossRef
6. Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03)
   Reo Hamaguchi et al, 2020, Supportive Care in Cancer CrossRef